Walnut Technologies


Non-invasive therapeutic ultrasound devices used to accelerate drug delivery and deliver perfusion therapy for stroke and peripheral thrombosis. Acquired privately in 2003.

Non-invasive therapeutic ultrasound devices used to accelerate drug delivery and deliver perfusion therapy for stroke and peripheral thrombosis. Acquired privately in 2003.

Company (Acquired)

Phone: 978-623-8111

Fax:

300 Brickstone Square

Andover, 01810
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Walnut Technologies $9.3M May 23, 2003
See all 19 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Walnut Technologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Carbylan Therapeutics

Newark, California, United States
AcquiredCarbylan Therapeutics is a clinical-stage, specialty, pharmaceutical company focused on the development and commercialization of proprietary combination therapies that address significant unmet medical needs. The company's initial focus is on the development of Hydros-TA, their proprietary, intra-articular injectable product candidate to treat pain associated with osteoarthritis of the knee. Carbylan Therapeutics previously traded on the Nasdaq Stock Market under the ticker CBYL.Login to see details

Ekos

Bothell, Washington, United States
AcquiredEKOS develops clinical application of ultrasound accelerated thrombolysis for the treatment of vascular thrombosis and dissolution of thrombus.Login to see details
See all 19 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)